China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015)
China Pharma Holdings (CPHI) reported Construction in Progress of $19,747 for Q3 2015, down 99.8% from $12.54 million a year earlier but up 234.9% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Construction in Progress (2011 - 2015) Analysis & Trends
At the end of FY2014, China Pharma Holdings posted Construction in Progress of $5,848, down 100.0% from FY2013.
- Construction in Progress has a three-year compound annual growth rate of -74.5% (FY2011 to FY2014).
- By year, Construction in Progress came in at $25.5 million in FY2013 (+591.3%), $3.69 million in FY2012 (+949.2%) and $351,571 in FY2011.
- Five-year quarterly Construction in Progress spans a low of $5,848 in Q4 2014 and a high of $29.72 million in Q2 2014.
- Year over year, Construction in Progress has now declined in each of the last five quarters, with growth averaging 120.2% over the last eight quarters.
- The high point for year-over-year Construction in Progress in five years was Q4 2012 (growth of 949.2%); the low point was Q2 2015 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q3 2015 came in at $5,896 (Q2 2015), $5,876 (Q1 2015) and $5,848 (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 19,747.00 |
| Jun 30, 2015 | 5,896.00 |
| Mar 31, 2015 | 5,876.00 |
| Dec 31, 2014 | 5,848.00 |
| Sep 30, 2014 | 12.54 Mn |
| Jun 30, 2014 | 29.72 Mn |
| Mar 31, 2014 | 29.01 Mn |
| Dec 31, 2013 | 25.50 Mn |
| Sep 30, 2013 | 15.67 Mn |
| Jun 30, 2013 | 10.34 Mn |
| Mar 31, 2013 | 4.13 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 361,999.00 |
| Jun 30, 2012 | 354,034.00 |
| Dec 31, 2011 | 351,571.00 |
API Access
China Pharma Holdings Construction in Progress API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=construction-in-progress&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "construction-in-progress", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=construction-in-progress&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();